Literature DB >> 9617722

Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders.

P Martínez-Martín1, B Frades Payo.   

Abstract

The present multicenter study evaluated the validity of the PDQ-39 Spanish version (PDQ-39 SV) for assessing health-related quality of life (QoL) in Parkinson's disease (PD). A total of 103 PD patients were evaluated by the Hoehn and Yahr stage and by the following scales: Unified Parkinson's Disease Rating Scale (UPDRS), Schwab and England scale, Pfeiffer's SPMSQ, and Geriatric Depression Scale. The Hospital Anxiety and Depression Scale and the PDQ-39 SV were self-completed by patients. For analysis of data we used descriptive statistics, Cronbach's alpha, Spearman's rank correlation coefficients, and the Kruskal-Wallis test. The internal consistency of the PDQ-39 SV dimensions was satisfactory (Cronbach's alpha: 0.63-0.94; item-total correlation: 0.57-0.87, P < 0.001), although Social Support and Cognition items were beneath ideal values. Recorded results for Mobility, Activities of Daily Living, and Communication were highly correlated with PD rating scales (rs = 0.49-0.73, P < 0.001). Emotional Well-Being and Body Pain showed their best correlations with mood measures. Cognition was the only dimension significantly correlated with the SPMSQ (RS = 0.27, P < 0.01). These data and previous studies indicate that the PDQ-39 is a consistent instrument for evaluation of physical, emotional, and psychosocial aspects of QoL in PD patients.

Entities:  

Mesh:

Year:  1998        PMID: 9617722     DOI: 10.1007/pl00007737

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Axial rigidity and quality of life in patients with Parkinson's disease: a preliminary study.

Authors:  Roberto Cano-de-la-Cuerda; Lydia Vela-Desojo; Juan Carlos Miangolarra-Page; Yolanda Macías-Macías; Elena Muñoz-Hellín
Journal:  Qual Life Res       Date:  2010-12-14       Impact factor: 4.147

3.  Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39).

Authors:  Z Katsarou; S Bostantjopoulou; V Peto; A Alevriadou; G Kiosseoglou
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

4.  Quality of life in Serbian patients with Parkinson's disease.

Authors:  Ljubomir Ziropada; Elka Stefanova; Aleksandra Potrebić; Vladimir S Kostić
Journal:  Qual Life Res       Date:  2009-06-27       Impact factor: 4.147

5.  Reliability and validity of PDQ-39: a quality-of-life measure for patients with PD in China.

Authors:  Jing-Lin Zhang; Piu Chan
Journal:  Qual Life Res       Date:  2011-10-09       Impact factor: 4.147

6.  Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson's Disease Questionnaire (PDQ-39).

Authors:  Wei Luo; Xiao-hong Gui; Bo Wang; Wen-ying Zhang; Zhi-yuan Ouyang; Yi Guo; Bao-rong Zhang; Mei-ping Ding
Journal:  J Zhejiang Univ Sci B       Date:  2010-07       Impact factor: 3.066

Review 7.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 8.  Health-related quality-of-life measurement in patients with Parkinson's disease.

Authors:  C Jenkinson; R Fitzpatrick; V Peto
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

9.  Charting the progression of disability in Parkinson disease: study protocol for a prospective longitudinal cohort study.

Authors:  Leland E Dibble; James T Cavanaugh; Gammon M Earhart; Terry D Ellis; Matthew P Ford; Kenneth B Foreman
Journal:  BMC Neurol       Date:  2010-11-03       Impact factor: 2.474

10.  The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson's disease.

Authors:  T H Haapaniemi; K A Sotaniemi; H Sintonen; E Taimela
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.